Le Lézard
Classified in: Health, Science and technology
Subject: PDT

tab32 Upgrades Patient-First Dental PMS System, Unveils New UX And Website


ROCKLIN, Calif., Sept. 21, 2021 /PRNewswire/ -- tab32, the dental industry's #1 cloud-based, full-service technology platform, today announced a complete overhaul of its dental practice management system (PMS), including a reimagined user experience (UX) and powerful new features to deliver a true, unified patient-first experience. The company also unveiled a new website to enable dental professionals, DSOs, and patients to quickly and easily explore its offerings.  

The upgrades come on the heels of tab32 raising a new Series B round in August, marking the culmination of five consecutive years of 100% year-on-year growth. The tab32 platform is now trusted by leading DSOs to manage over 7.3 million patient relationships, including 9.3 million appointments, more than 100 million radiographic records, and over 1 million monthly patient engagements. Already profitable for two straight years, tab32 is rapidly expanding, and recently signed several high-profile new clients including national dental service organizations (DSOs) such as Specialty Dental Brands, Lightwave Dental, and Smile Dental Services.

The new UX and website design reflect tab32's continuing commitment to providing the dental industry with the most streamlined, straightforward, and comprehensive tech solution on the market. The revamped platform includes powerful new workflows designed to efficiently meet the needs of individual practices, regional organizations, and national executives. Some of the most sought-after features include:

"With these new features, UX, and website we're continuing tab32's patient-first approach to driving growth and improving outcomes in the ever-changing dental retail market," said Kiltesh Patel, CEO and founder of tab32. "Designed from the ground up to serve multi-location, multi-specialty dental practice groups, our cloud-first, future-forward PMS continues to evolve and adapt to not only support DSO's present goals, but also anticipate their future needs as they grow and expand."

About tab32
Headquartered in Sacramento, California, tab32 is the industry's #1 technology platform for patient-first cloud dental electronic health record software (Dental EHR), Dental Practice Management System (Dental PMS), and Open Data Warehousingtm. Providers use tab32 to track 9.3 million appointments, 7.3 million patients, and 100+ million radiology xrays, with 1+ million monthly patient engagements and $375 million of annual revenues flowing through the platform. The all-in-one cloud platform delivers comprehensive and engaging patient experiences through the entire value-chain of care, allowing dental practices to achieve long-term sustainable growth and profitability. With a leadership team of former researchers, data scientists, and engineers from University of California, tab32 has pioneered many first-to-market innovations such as integrated texting, VoIP, e-forms, mobile payments, cloud imaging, and a Standard Model for open data sharing in dental.

SOURCE tab32


These press releases may also interest you

at 02:05
Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the launch of the breakthrough in-hospital Nu.Q® Canine Cancer Test in Europe. A...

at 02:00
Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan. Participants of this round are: Beyond Next Ventures Inc.The University of Tokyo Edge Capital Partners Co., Ltd.Keio...

at 01:05
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care...

at 01:01
Allied Market Research published a report, titled, "Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus...

at 00:49
Allied Market Research published a report, titled, "Inhaled Nitric Oxide Market by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease, Acute Respiratory Distress Syndrome, and Others): Global Opportunity Analysis and...

at 00:45
Vertex Pharmaceuticals Incorporated and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to TreeFrog's proprietary cell manufacturing technology, C-StemTM, to optimize production...



News published on and distributed by: